Hyphally regulated protein 1 (Hyr1p)

Hyphally regulated protein 1 (Hyr1p) is a major cell wall surface antigen of the opportunistic fungal pathogen Candida albicans, specifically expressed during its hyphal (filamentous) growth phase (Luo et al., 2010). It is a glycosylphosphatidylinositol (GPI)-anchored protein that plays a critical role in fungal virulence by mediating resistance to host innate immune defenses, particularly neutrophil-mediated killing (Luo et al., 2010). Hyr1p functions by shielding the fungus from phagocytic attack, thereby facilitating disseminated infection and biofilm formation on mucosal surfaces (Nobile et al., 2006). Beyond its role in candidiasis, Hyr1p exhibits significant structural homology with surface proteins of certain Gram-negative bacteria, such as Acinetobacter baumannii and Klebsiella pneumoniae, making it a unique cross-kingdom therapeutic target (Uppuluri et al., 2018). Therapeutic strategies targeting Hyr1p include active vaccination with recombinant N-terminal fragments (rHyr1p-N) and passive immunization with monoclonal antibodies (Singh et al., 2020). These interventions aim to neutralize the protein's protective effects, thereby enhancing the ability of neutrophils to eliminate the pathogen and preventing the formation of mixed-species biofilms (Uppuluri et al., 2018). Clinical interest in Hyr1p is driven by its potential to treat invasive candidiasis, neonatal fungal sepsis, and multidrug-resistant bacterial infections, often in synergy with existing antifungal agents (Ibrahim et al., 2010).

Other names

Hyr1Hyphally-regulated protein 1Candida albicans Hyr1Hyr1 proteinCandida albicans Hyr1p surface antigen

Neutralization of Hyr1p-mediated resistance to neutrophil killing and blocking of microbial adhesion and invasion.